Salvador, Nikki Fae .

HRN: 28-83-19  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/14/2026
CEFUROXIME 500MG (TAB)
05/14/2026
05/21/2026
ORAL
500mg
BID
S/P NSVD With RMLE And Repair
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines